Results 21 to 30 of about 3,912,192 (199)

What do Libyan doctors perceive as the benefits, ethical issues and influences of their interactions with pharmaceutical company representatives?

open access: yesThe Pan African Medical Journal, 2013
BACKGROUND: Evidence suggests that 80-90% of doctors in most countries across the world are frequently visited by pharmaceutical company representatives (PCRs).
Mustafa Ali Alssageer   +1 more
doaj   +1 more source

The Effect of Modern Educational Strategies in Reducing Intravenous Drug Administration Error: A Non-Randomized Clinical Trial [PDF]

open access: yesمجله ایرانی آموزش در علوم پزشکی, 2012
Introduction: Among medication errors, intravenous medication administration errors are especially important. The lack of medication information can be one of the causes of medication errors.
Nasrin Sharifi   +2 more
doaj  

Knowledge among Drug Dispensers and Antimalarial Drug Prescribing Practices in Public Health Facilities in Dar es Salaam. [PDF]

open access: yes, 2013
Irrational prescribing and dispensing of antimalarials has been identified as a contributing factor in the emergence of malaria parasites resistant to existing antimalarial drugs.
Kamuhabwa, Appolinary Ar   +1 more
core   +2 more sources

Use of drug information resources by the community pharmacist in Penang, Malaysia

open access: yesJournal of Innovation in Health Informatics, 2010
Purpose This study aimed to identify the types of drug information resources used by community pharmacists in daily practice in Penang, Malaysia. Method A cross-sectional based survey was conducted among randomly selected community pharmacists in Penang ...
Mohamed Hassali   +2 more
doaj   +1 more source

Development and design of the BELpREG registration system for the collection of real-world data on medication use in pregnancy and mother-infant outcomes

open access: yesFrontiers in Drug Safety and Regulation, 2023
Although medication use during pregnancy is common, most available products lack sufficient safety information. As prospective data collection and perinatal pharmacoepidemiologic research on medication safety in pregnancy did not exist in Belgium yet ...
Laure Sillis   +26 more
doaj   +1 more source

Disclosure of Clinical Trial Data: Why Exemption 4 of the Freedom of Information Act Should Be Restored [PDF]

open access: yes, 2005
Clinical trial data generated during the FDA drug approval process can be very valuable. While patients and doctors desperately need this information to make informed choices about medical treatment, drug sponsors strive to keep this resource secret to ...
Boyce, Janene
core   +2 more sources

PROVISION OF CLINICAL PHARMACY SERVICES THROUGH THE TELEGRAM GROUP UNDER THE CONDITIONS OF THE FULL-SCALE WAR IN UKRAINE

open access: yesActa Medica Leopoliensia, 2023
The research aims at studying the requirement for clinical pharmacy services offered through the activity of a Telegram group after the imposition of martial law in Ukraine. Materials and Methods.
Andriy Zimenkovsky   +7 more
doaj   +1 more source

Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. [PDF]

open access: yes, 2008
BackgroundPrevious studies of drug trials submitted to regulatory authorities have documented selective reporting of both entire trials and favorable results.
Bacchetti, Peter   +2 more
core   +3 more sources

Evaluation of HIV/AIDS patients' knowledge on antiretroviral drugs

open access: yesBrazilian Journal of Infectious Diseases
Lack of information on antiretroviral drugs or the misunderstanding of available information can facilitate incorrect use of such drugs. This can result in non-adherence to the prescribed regimen, leading to a great possibility of a therapeutic failure ...
Regina Flávia de Castro Almeida   +1 more
doaj   +1 more source

Evaluation of drug information resources for interactions between therapeutic drugs and drugs of abuse

open access: yesJournal of the Medical Library Association, 2020
Objective: The research evaluated point-of-care resources for scope, completeness, and consistency of information describing interactions between therapeutic drugs and drugs of abuse (DoA).
Robert D. Beckett   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy